Advertisement

Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies

Andreas Agathangelidis, Nikos Darzentas, Anastasia Hadzidimitriou, Xavier Brochet, Fiona Murray, Xiao-Jie Yan, Zadie Davis, Ellen J. van Gastel-Mol, Cristina Tresoldi, Charles C. Chu, Nicola Cahill, Veronique Giudicelli, Boris Tichy, Lone Bredo Pedersen, Letizia Foroni, Lisa Bonello, Agnieszka Janus, Karin Smedby, Achilles Anagnostopoulos, Helene Merle-Beral, Nikolaos Laoutaris, Gunnar Juliusson, Paola Francia di Celle, Sarka Pospisilova, Jesper Jurlander, Christian Geisler, Athanasios Tsaftaris, Marie-Paule Lefranc, Anton W. Langerak, David Graham Oscier, Nicholas Chiorazzi, Chrysoula Belessi, Frederic Davi, Richard Rosenquist, Paolo Ghia and Kostas Stamatopoulos

Article Information

Citation 
vol. 119 no. 19 4467-4475
PubMed 

Print ISSN 
Online ISSN 
History 
  • Submitted November 26, 2011
  • Accepted February 26, 2012
  • Published online May 10, 2012.

Article Versions


Contributors 
  • Andreas Agathangelidis, 1Institute of Agrobiotechnology, Center for Research and Technology Hellas, Thessaloniki, Greece;
  • Nikos Darzentas, 1Institute of Agrobiotechnology, Center for Research and Technology Hellas, Thessaloniki, Greece;
  • Anastasia Hadzidimitriou, 1Institute of Agrobiotechnology, Center for Research and Technology Hellas, Thessaloniki, Greece;
  • Xavier Brochet, 2IMGT, Université Montpellier 2, Laboratoire d'ImmunoGénétique Moléculaire, Institut de Génétique Humaine, UPR Centre National de la Recherche Scientifique 1142, Montpellier, France;
  • Fiona Murray, 3Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden;
  • Xiao-Jie Yan, 4The Feinstein Institute for Medical Research, North Shore–Long Island Jewish Health System, Manhasset, NY;
  • Zadie Davis, 5Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom;
  • Ellen J. van Gastel-Mol, 6Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands;
  • Cristina Tresoldi, 7Unit of Molecular Hematology, Istituto Scientifico San Raffaele, Milan, Italy;
  • Charles C. Chu, 4The Feinstein Institute for Medical Research, North Shore–Long Island Jewish Health System, Manhasset, NY;
  • Nicola Cahill, 8Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden;
  • Veronique Giudicelli, 2IMGT, Université Montpellier 2, Laboratoire d'ImmunoGénétique Moléculaire, Institut de Génétique Humaine, UPR Centre National de la Recherche Scientifique 1142, Montpellier, France;
  • Boris Tichy, 9Department of Hematooncology, University Hospital Brno and Central European Institute of Technology, Masaryk University, Brno, Czech Republic;
  • Lone Bredo Pedersen, 10Department of Hematology, Rigshospitalet, Copenhagen, Denmark;
  • Letizia Foroni, 11Department of Haematology, Imperial College Academic Health Science Centre, Hammersmith Hospital, London, United Kingdom;
  • Lisa Bonello, 12Center for Experimental Research and Medical Studies, S. Giovanni Battista Hospital, Turin, Italy;
  • Agnieszka Janus, 13Laboratory of B Cell Neoplasia and Unit of Lymphoid Malignancies, Università Vita-Salute San Raffaele and Istituto Scientifico San Raffaele, Milan, Italy;
  • Karin Smedby, 14Department of Medicine, Clinical Epidemiology Unit, Karolinska Institutet, Stockholm, Sweden;
  • Achilles Anagnostopoulos, 15Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece;
  • Helene Merle-Beral, 16Hematology Department and University Pierre et Marie Curie, Hôpital Pitié-Salpètrière, Paris, France;
  • Nikolaos Laoutaris, 17Hematology Department, Nikea General Hospital, Piraeus, Greece; and
  • Gunnar Juliusson, 18Lund University and Hospital Department of Hematology, Lund Stem Cell Center, Lund, Sweden
  • Paola Francia di Celle, 12Center for Experimental Research and Medical Studies, S. Giovanni Battista Hospital, Turin, Italy;
  • Sarka Pospisilova, 9Department of Hematooncology, University Hospital Brno and Central European Institute of Technology, Masaryk University, Brno, Czech Republic;
  • Jesper Jurlander, 10Department of Hematology, Rigshospitalet, Copenhagen, Denmark;
  • Christian Geisler, 10Department of Hematology, Rigshospitalet, Copenhagen, Denmark;
  • Athanasios Tsaftaris, 1Institute of Agrobiotechnology, Center for Research and Technology Hellas, Thessaloniki, Greece;
  • Marie-Paule Lefranc, 2IMGT, Université Montpellier 2, Laboratoire d'ImmunoGénétique Moléculaire, Institut de Génétique Humaine, UPR Centre National de la Recherche Scientifique 1142, Montpellier, France;
  • Anton W. Langerak, 6Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands;
  • David Graham Oscier, 5Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom;
  • Nicholas Chiorazzi, 4The Feinstein Institute for Medical Research, North Shore–Long Island Jewish Health System, Manhasset, NY;
  • Chrysoula Belessi, 17Hematology Department, Nikea General Hospital, Piraeus, Greece; and
  • Frederic Davi, 16Hematology Department and University Pierre et Marie Curie, Hôpital Pitié-Salpètrière, Paris, France;
  • Richard Rosenquist, 8Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden;
  • Paolo Ghia, 13Laboratory of B Cell Neoplasia and Unit of Lymphoid Malignancies, Università Vita-Salute San Raffaele and Istituto Scientifico San Raffaele, Milan, Italy;
  • Kostas Stamatopoulos, 1Institute of Agrobiotechnology, Center for Research and Technology Hellas, Thessaloniki, Greece; 15Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece;

Altmetric.com Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output